The role of KLK6 in pancreatic cancer might be further explored in vivo by using for example an orthotopic xenograft approach, whereby tumour spheroids established from KLK6-expressing and KLK6-deficient PDAC cells are positioned adjacent to the pancreas [4]. Here, KLK6 is linked to familial pancreatic carcinoma.